Episode Details

Back to Episodes
LIFTS Episode 24 - Costco Launches GLP-1 Prescriptions | Technogym's Positive Performance - LIFTS w/ Guest Lise Kuecker

LIFTS Episode 24 - Costco Launches GLP-1 Prescriptions | Technogym's Positive Performance - LIFTS w/ Guest Lise Kuecker

Published 1 year, 8 months ago
Description

In this week's episode of LIFTS – your a bite-size dose of the Latest Industry Fitness Trends and Stories - hosts Matthew Januszek, Co-Founder of Escape Fitness and Mo Iqbal, Founder & CEO of Sweatworks, are joined by Lisa Kuecker, serial entrepreneur, public speaker and founder of international boutique fitness consultancy sensation, Studio Grow.

In this LIFTS podcast, topics include:

● GLP-1s move into mainstream via COSTCO prescriptions.

● The positive effect of exercise for those taking GLP-1s.

● Merger of Orangetheory and Self Esteem Brands (Anytime Fitness).

● Fitness franchises and expansion strategies.

● Technogym's impressive financial 2023 performance.

● The huge commercial opportunity presented by the sale of used equipment.

● Shift from hardware to service – The next play for fitness kit provider.

======================================================

Subscribe to our YouTube channel and turn on your notifications so you never miss a new video when it's published: https://www.youtube.com/user/EscapeFitness

Shop gym equipment: https://escapefitness.com/shop

View our full catalog:

https://escapefitness.com/support/catalog

https://escapefitness.com/support/catalogue

======================================================

Facebook: https://www.facebook.com/Escapefitness

Instagram: https://www.instagram.com/escapefitness

Twitter: https://www.twitter.com/escapefitness

LinkedIn: https://www.linkedin.com/company/escapefitness/

0:00 Intro

02:45 Introducing Lisa Kuecker, founder, Studio Grow

04:28 The value of taking intentional time off work

06:21 Introduction of GLP-1 prescriptions b

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us